Zimbabwe has declined a substantial American health deal valued at $367m (£272m) spanning five years due to Washington's demand for sensitive data.
The decision came to light following a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government spokesman later stated that the United States was demanding access to biological samples for research and commercial purposes while was not willing to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for continued negotiations to reach a deal suitable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Implications
This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had overseen aid for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance openness and responsibility.
According to statements, Sixteen African countries have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our citizens if a future pandemic arise."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks already established via the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.
"This framework is designed to guarantee that when a nation provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
These objections regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how subsequent collaboration could be arranged in a way that respects the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body stated it understood the government's concerns, but recommended that negotiations need to persist since a large portion of the nation's Aids initiatives depended on foreign aid.
"In cases where specific concerns exist, including those involving information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group said.
This impasse emphasises the ongoing challenges between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.